PL366027A1 - Wydajny sposób wytwarzania inhibitora czynnika Xa - Google Patents
Wydajny sposób wytwarzania inhibitora czynnika XaInfo
- Publication number
- PL366027A1 PL366027A1 PL01366027A PL36602701A PL366027A1 PL 366027 A1 PL366027 A1 PL 366027A1 PL 01366027 A PL01366027 A PL 01366027A PL 36602701 A PL36602701 A PL 36602701A PL 366027 A1 PL366027 A1 PL 366027A1
- Authority
- PL
- Poland
- Prior art keywords
- inhibitor
- factor
- preparation
- efficient process
- efficient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23462200P | 2000-09-22 | 2000-09-22 | |
PCT/US2001/028406 WO2002024690A2 (en) | 2000-09-22 | 2001-09-12 | Efficient process for the preparation of a factor xa inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
PL366027A1 true PL366027A1 (pl) | 2005-01-24 |
Family
ID=22882119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL01366027A PL366027A1 (pl) | 2000-09-22 | 2001-09-12 | Wydajny sposób wytwarzania inhibitora czynnika Xa |
Country Status (23)
Country | Link |
---|---|
US (3) | US6667332B2 (pl) |
EP (1) | EP1366045A2 (pl) |
JP (1) | JP2004529853A (pl) |
KR (1) | KR20040043089A (pl) |
CN (1) | CN1610679A (pl) |
AU (1) | AU2001292612A1 (pl) |
BG (1) | BG107813A (pl) |
BR (1) | BR0114102A (pl) |
CA (1) | CA2424576A1 (pl) |
CZ (1) | CZ2003835A3 (pl) |
EE (1) | EE200300116A (pl) |
HR (1) | HRP20030316A2 (pl) |
HU (1) | HUP0500133A2 (pl) |
IL (1) | IL155043A0 (pl) |
IS (1) | IS6754A (pl) |
MX (1) | MXPA03002493A (pl) |
NO (1) | NO20031308L (pl) |
PL (1) | PL366027A1 (pl) |
RU (1) | RU2003111464A (pl) |
SK (1) | SK4892003A3 (pl) |
TW (1) | TW593314B (pl) |
WO (1) | WO2002024690A2 (pl) |
ZA (1) | ZA200302971B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
JP2004504295A (ja) * | 2000-07-18 | 2004-02-12 | ボーン ケア インターナショナル インコーポレイテッド | 安定化1α−ヒドロキシビタミンD |
TW200302225A (en) * | 2001-12-04 | 2003-08-01 | Bristol Myers Squibb Co | Substituted amino methyl factor Xa inhibitors |
WO2004031143A2 (en) | 2002-10-02 | 2004-04-15 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
KR100630029B1 (ko) | 2002-11-06 | 2006-09-27 | 마츠시타 덴끼 산교 가부시키가이샤 | 변위 검출 기능을 구비한 마이크로 액츄에이터, 및 당해마이크로 액츄에이터를 구비한 가변형 미러 |
US7429581B2 (en) * | 2002-12-23 | 2008-09-30 | Sanofi-Aventis Deutschland Gmbh | Pyrazole-derivatives as factor Xa inhibitors |
US20050059719A1 (en) * | 2003-09-16 | 2005-03-17 | Badawy Sherif Ibrahim Farag | Solid dosage formulation containing a Factor Xa inhibitor and method |
KR20230042384A (ko) | 2014-03-07 | 2023-03-28 | 바이오크리스트파마슈티컬즈,인코포레이티드 | 인간 혈장 칼리크레인 저해제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
ZA985247B (en) * | 1997-06-19 | 1999-12-17 | Du Pont Merck Pharma | Guanidine mimics as factor Xa inhibitors. |
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
-
2001
- 2001-09-12 AU AU2001292612A patent/AU2001292612A1/en not_active Abandoned
- 2001-09-12 PL PL01366027A patent/PL366027A1/pl not_active Application Discontinuation
- 2001-09-12 SK SK489-2003A patent/SK4892003A3/sk not_active Application Discontinuation
- 2001-09-12 KR KR10-2003-7004196A patent/KR20040043089A/ko not_active Application Discontinuation
- 2001-09-12 EP EP01972987A patent/EP1366045A2/en not_active Withdrawn
- 2001-09-12 JP JP2002529100A patent/JP2004529853A/ja active Pending
- 2001-09-12 CN CNA018193064A patent/CN1610679A/zh active Pending
- 2001-09-12 CA CA002424576A patent/CA2424576A1/en not_active Abandoned
- 2001-09-12 CZ CZ2003835A patent/CZ2003835A3/cs unknown
- 2001-09-12 MX MXPA03002493A patent/MXPA03002493A/es unknown
- 2001-09-12 WO PCT/US2001/028406 patent/WO2002024690A2/en not_active Application Discontinuation
- 2001-09-12 RU RU2003111464/04A patent/RU2003111464A/ru not_active Application Discontinuation
- 2001-09-12 EE EEP200300116A patent/EE200300116A/xx unknown
- 2001-09-12 HU HU0500133A patent/HUP0500133A2/hu unknown
- 2001-09-12 IL IL15504301A patent/IL155043A0/xx unknown
- 2001-09-12 BR BR0114102-3A patent/BR0114102A/pt not_active IP Right Cessation
- 2001-09-21 US US09/960,040 patent/US6667332B2/en not_active Expired - Fee Related
- 2001-09-21 TW TW090123363A patent/TW593314B/zh not_active IP Right Cessation
-
2003
- 2003-03-21 NO NO20031308A patent/NO20031308L/no not_active Application Discontinuation
- 2003-03-21 IS IS6754A patent/IS6754A/is unknown
- 2003-04-15 ZA ZA200302971A patent/ZA200302971B/en unknown
- 2003-04-22 HR HR20030316A patent/HRP20030316A2/hr not_active Application Discontinuation
- 2003-05-07 US US10/431,265 patent/US6747158B2/en not_active Expired - Fee Related
- 2003-05-13 BG BG107813A patent/BG107813A/bg unknown
-
2004
- 2004-04-15 US US10/826,099 patent/US20040198787A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2003111464A (ru) | 2004-10-27 |
EE200300116A (et) | 2005-04-15 |
SK4892003A3 (en) | 2004-04-06 |
NO20031308D0 (no) | 2003-03-21 |
CA2424576A1 (en) | 2002-03-28 |
WO2002024690A8 (en) | 2002-08-08 |
WO2002024690A3 (en) | 2003-09-25 |
US20020061917A1 (en) | 2002-05-23 |
HUP0500133A2 (hu) | 2005-04-28 |
JP2004529853A (ja) | 2004-09-30 |
MXPA03002493A (es) | 2004-09-10 |
WO2002024690A2 (en) | 2002-03-28 |
US6667332B2 (en) | 2003-12-23 |
US20030212117A1 (en) | 2003-11-13 |
IS6754A (is) | 2003-03-21 |
EP1366045A2 (en) | 2003-12-03 |
BR0114102A (pt) | 2005-04-19 |
IL155043A0 (en) | 2003-10-31 |
TW593314B (en) | 2004-06-21 |
NO20031308L (no) | 2003-05-07 |
AU2001292612A1 (en) | 2002-04-02 |
US20040198787A1 (en) | 2004-10-07 |
ZA200302971B (en) | 2005-05-09 |
KR20040043089A (ko) | 2004-05-22 |
CN1610679A (zh) | 2005-04-27 |
US6747158B2 (en) | 2004-06-08 |
CZ2003835A3 (cs) | 2003-12-17 |
BG107813A (bg) | 2004-01-30 |
HRP20030316A2 (en) | 2005-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273040A1 (en) | Factor xa inhibitors | |
PT1330370E (pt) | Processo para o fabrico de elementos de superfície | |
HUP0402027A3 (en) | Process for the preparation of a xantophyll | |
GB0025221D0 (en) | New process | |
SG99351A1 (en) | Process for the manufacture of a crystalline solid | |
HK1063803A1 (en) | Process for the preparation of a 14-hydroxynormorphinone derivative | |
PL366027A1 (pl) | Wydajny sposób wytwarzania inhibitora czynnika Xa | |
PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
HK1048112B (zh) | 3-乙烯基-頭孢化合物的製備方法 | |
GB0031094D0 (en) | New Process | |
HK1052350A1 (zh) | 一種合成嗎啉基苯類化合物的新方法 | |
GB0014546D0 (en) | A novel process | |
GB0107062D0 (en) | A mortar table | |
HK1051846A1 (en) | A process for the purification of diacerein | |
HUP0300381A3 (en) | New coupling process | |
IL155189A0 (en) | NOVEL CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR | |
GB0025940D0 (en) | Solvogels & a method of manufacturing the same | |
GB0012448D0 (en) | New process | |
AU141604S (en) | A set of partition jointers | |
GB0105911D0 (en) | Process for making a thrombon inhibitor | |
AU744296C (en) | A process for the reduction of pterins | |
GB0010572D0 (en) | A set of parts | |
AU5600001A (en) | Delamination process | |
AU147773S (en) | A set of clamps | |
GB0004895D0 (en) | Inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |